Gobbi et al. showed that downregulated TβRII was associated with an increased risk of developing invasive breast cancer, and the absence of TβRII correlated with high-grade human carcinoma in situ and invasive breast cancer [7,10]. The gene discussed is TGFBR2; the disease is invasive breast carcinoma.